Fucoidan, a major component of brown seaweed, prohibits the growth of human cancer cell lines in vitro
Evaluation of growth prohibition in renal cancer cell lines.
Renal Cancer
Renal Cancer
Use of fucoidan to treat renal diseases: A review of 15 years of clinic studies
Comprehensive review of 15 years of clinical studies on Fucoidan for renal disease treatment.
Urinary Bladder Cancer
Fucoidan induces G1 arrest of the cell cycle in EJ human bladder cancer cells through down-regulation of pRB phosphorylation
Mechanism of G1-phase arrest through down-regulation of pRB phosphorylation.
Urinary Bladder Cancer
Fucoidan Inhibits the Proliferation of Human Urinary Bladder Cancer T24 Cells by Blocking Cell Cycle Progression and Inducing Apoptosis
Robust anti-proliferative effects against T24 bladder cancer cells.
AKT signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells
Inhibition of migration and invasion via AKT signaling pathway.
Urinary Bladder Cancer
Natural Products as New Approaches for Treating Bladder Cancer: From Traditional Medicine to Novel Drug Discovery
Review of natural products including fucoidan for bladder cancer
Colon Cancer
Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer
Some studies show fucoidan enhances the effects of chemotherapy drugs like 5-FU and oxaliplatin while reducing side effects.
Lung Cancer
Fucoidan from seaweed Fucus vesiculosus inhibits migration and invasion of human lung cancer cell via PI3K-Akt-mTOR pathways
Inhibition of lung cancer cell growth and metastasis via modulation of PI3K-Akt-mTOR pathways.
Liver Cancer
Study of Oligo-Fucoidan in Advanced Hepatocellular Carcinoma (HCC)
First completed randomized, double-blind, placebo-controlled trial in HCC, comparing oligo-fucoidan alongside standard care.